Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	EWEdwards Lifesciences	IDXXIdexx Laboratories	BDXBecton Dickinson
Snapshot
Price	$85.88	$545.73	$140.71
Market cap	$50.30B	$44.34B	$39.67B
Valuation
P/E	45.8x	40.5x	35x
Forward P/E	65.5x	32.3x	46.6x
Growth
Revenue growth	13.8%	13.1%	2.4%
EPS growth	-73.2%	25.6%	-24.8%
Profitability
Net margin	17.4%	24.6%	5.3%
ROE	10.6%	70.9%	4.5%
Balance sheet & cash
Debt / equity	0.06x	0.53x	0.76x
Free cash flow yield	2.9%	1.9%	9.0%
Dividend yield	—	—	2.9%
Verdict
Investment rating	Neutral· 47	Favorable· 65	Weak· 37

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	EWtoday $86	IDXXtoday $546	BDXtoday $141
2027	$65.70 – $96.36+12% CAGR	$514.04 – $753.92+38% CAGR	$107.64 – $157.88+12% CAGR
2028	$67.01 – $98.28+7% CAGR	$645.58 – $946.85+32% CAGR	$109.80 – $161.03+7% CAGR
2029	$68.35 – $100.25+5% CAGR	$810.78 – $1,189.15+30% CAGR	$111.99 – $164.25+5% CAGR
2030	$69.72 – $102.26+4% CAGR	$1,018.26 – $1,493.45+29% CAGR	$114.23 – $167.54+4% CAGR
2031	$71.11 – $104.30+4% CAGR	$1,278.83 – $1,875.62+28% CAGR	$116.52 – $170.89+4% CAGR
5-yr CAGR	-3.7% – 4.0%	18.6% – 28.0%	-3.7% – 4.0%